Projects per year
Personal profile
Personal profile
Dr. Ding has an interdisciplinary education background from biotechnology to pharmaceutics, and biomaterials science and engineering. His research focuses on the development of biocompatible carrier-based nanomedicines, transdermal drug delivery systems and microfluidics-based technologies for multimodal treatments (e.g., chemotherapy, phototherapy and immunotherapy) of various diseases including cancers and inflammations. Dr. Ding has published nearly 30 SCI papers, including 17 of them with him as the (co-)corresponding/first author in top journals such as Adv. Mater., ACS Nano, Biomaterials, Chem. Eng. J., Nano Lett., and J. Control. Release. He also published one chapter of an international book regarding microfluidics. He has been granted 5 invention patents by the United States, China, Japan and the Europe, and has won several awards including the Patent Excellence Award of China (2020) and Science and Technology Progress Award of Taizhou City ( First Prize) (2015). Dr. Ding warmly welcomes students interested in the research of biomaterials, drug delivery systems and microfluidics to join the lab. He also welcomes enterprises that have needs in the design and improvement of formulations to cooperate, including the development and application of traditional formulations (controlled-release microspheres, hydrogels, etc.) as well as nanomedicines, and transdermal formulations such as microneedles.
Experience
2024-present, Associate Professor (Researcher), Academy of Pharmacy, XJTLU, Suzhou, China
2019-2024, Professor, College of Pharmaceutical Sciences, Soochow University, Suzhou, China
2016-2019, Postdoctoral Associate, Singapore-MIT Alliance for Research and Technology (SMART), Singapore
2015-2016, Project Officer/Research Fellow, School of Materials Science and Engineering, Nanyang Technological University, Singapore
Research interests
(1) Synergistic tumor treatment via biocompatible nanomedicines (Chemotherapy, phototherapy, immunotherapy etc.)
(2) Transdermal drug delivery systems (Patches, microneedles etc.)
(3) Oral and topical drug delivery systems (Sustained-release microparticles etc.)
(4) Microfluidics and their applications in biomedicine
Awards and honours
(1) Patent Excellence Award of China (2020)
(2) The Science and Technology Progress Award of Taizhou City (First Prize) (2015)
(3) Best Poster Award, 6th Materials Research Society-Singapore Conference on Advanced Materials (2014)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
Bachelor, Nanjing University
Master, Nanjing University
PhD, Nanyang Technological University
Research areas
- Drug delivery
- Biomaterials
- Tumor treatment
Keywords
- RS Pharmacy and materia medica
- Drug delivery system
- Nanomedicine
- Transdermal drug delivery
- Tumor treatment
- Microfluidics
Person Types
- Staff
Fingerprint
Dive into the research topics where Dawei Ding is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The synergy of IDO1 expression modulation and lactobacillus for enhanced tumor photodynamic immunotherapy
Ding, D. (PI)
1/07/25 → 30/06/28
Project: Internal Research Project
-
Single-Molecule Single-Cell Imaging and Analysis Innovation Platform
Ruan, G. (PI), Zhang, X. (Team member), Wang, Y. (Team member), Zhou, Z. (Team member), Zhang, J. (Team member), Ding, D. (Team member), Ling, C. (Team member), Wu, Q. (Team member), Xu, P. (Team member), Ho, J. (Team member), Cheng, K. (Team member), Song, J. (Team member), Guo, B. (Team member), Wu, S. (Team member), Wang, J. (Team member), Sun, Y. (Team member), Lu, T. (Team member), Li, T. (Team member), Xu, Y. (Team member), Huang, D. (Team member), Cao, S. (Team member), Leng, J. (Team member) & Wen, X. (Team member)
1/10/24 → 30/09/26
Project: Governmental Research Project
-
The study of single molecular albumin nanoparticles for synergistic photo-immunotherapy of pancreatic cancers and their sensitizing mechanism
Chen, H. (PI), Ding, D. (CoPI), Deng, Y. (CoPI) & Liu, F. (CoPI)
1/01/24 → 31/12/28
Project: Governmental Research Project
-
The study of hypoxia relief for the remodeling of tumor immune microenvironment and the synergistic immunotherapy of breast cancer
Ding, D. (PI)
1/10/23 → 30/09/25
Project: Governmental Research Project
-
The research and development of protein-based sustained-release formulation of progesterone
Ding, D. (PI)
1/09/22 → 31/10/24
Project: Other
-
Core-shell vector-mediated co-delivery of CRISPR/Cas9 system and hydrophobic drugs against triple-negative breast cancer stem cells
Wang, T., Chen, T., Li, D., Hang, X., Zhang, S., Yi, H., Jiang, T., Ding, D. & Zhang, X., 10 Feb 2025, In: Journal of Controlled Release. 378, p. 1080-1091 12 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy
Xu, T., Liu, K., Mi, S., Yao, Y., Zhang, M., Xue, S., Zhi, F., Cryan, S. A. & Ding, D., Apr 2025, In: Materials Today Bio. 31, 101530.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief
He, M., Zhang, M., Xu, T., Xue, S., Li, D., Zhao, Y., Zhi, F. & Ding, D., Apr 2024, In: Journal of Controlled Release. 368, p. 233-250 18 p.Research output: Contribution to journal › Article › peer-review
35 Citations (Scopus) -
Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy
Wang, M., He, M., Zhang, M., Xue, S., Xu, T., Zhao, Y., Li, D., Zhi, F. & Ding, D., Oct 2023, In: Biomaterials. 301, 122257.Research output: Contribution to journal › Article › peer-review
47 Citations (Scopus) -
Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment
Wang, Y., Yue, C., Zhang, M., Li, D., Xu, T., He, M., Wang, M., Zhao, Y., Ni, Z., Zhi, F., Hu, Y. & Ding, D., 15 Jan 2023, In: Chemical Engineering Journal. 452, 139108.Research output: Contribution to journal › Article › peer-review
34 Citations (Scopus)
Activities
- 2 External examiner for PhD thesis
-
External PhD thesis examiner
Dawei Ding (External PhD examiner)
20 Jun 2025Activity: Supervision › External examiner for PhD thesis
-
External examiner for PhD thesis
Dawei Ding (External PhD examiner)
17 Jan 2025Activity: Supervision › External examiner for PhD thesis